ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,000 | -50.0% | 47 | -63.8% | 0.00% | -33.3% |
| Q2 2021 | $16,000 | -15.8% | 130 | -7.8% | 0.00% | -25.0% |
| Q1 2021 | $19,000 | -17.4% | 141 | -22.5% | 0.00% | -20.0% |
| Q4 2020 | $23,000 | +9.5% | 182 | -3.7% | 0.01% | -16.7% |
| Q3 2020 | $21,000 | +61.5% | 189 | -21.2% | 0.01% | +100.0% |
| Q4 2019 | $13,000 | +30.0% | 240 | -8.4% | 0.00% | -40.0% |
| Q3 2019 | $10,000 | 0.0% | 262 | +9.2% | 0.01% | +25.0% |
| Q2 2019 | $10,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |